SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis. It also develops NEUTRALIZE-AKI, an SCD therapy that is in clinical trials for adult patients with AKI; and other products in various therapeutic areas, including cardiorenal syndrome, hepatorenal syndrome, and myocardial stunning in end-stage renal disease. SeaStar Medical Holding Corporation was founded in 2007 and is headquartered in Denver, Colorado.
Frequently asked questions
What sector does LMF Acquisition Opportunities Inc (ICU) operate in?
LMF Acquisition Opportunities Inc belongs to the Healthcare sector and operates in the Biotechnology industry.
What is LMF Acquisition Opportunities Inc (ICU) current stock price?
As of the latest data, LMF Acquisition Opportunities Inc stock price is $2.52, with a previous close of $2.47. LMF Acquisition Opportunities Inc gained $0.05 in the last trading session, representing a 2.02% increase.
What is LMF Acquisition Opportunities Inc (ICU) current market capitalization?
LMF Acquisition Opportunities Inc market cap is approximately 13.26 million.
What is LMF Acquisition Opportunities Inc (ICU) Earnings Per Share (EPS)?
The trailing EPS is -$2.97, and the forward EPS is -$2.34.
What is LMF Acquisition Opportunities Inc (ICU) EBITDA?
LMF Acquisition Opportunities Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -3.71 million.
Does LMF Acquisition Opportunities Inc (ICU) pay dividends?
No. LMF Acquisition Opportunities Inc does not pay a dividend.
How did LMF Acquisition Opportunities Inc (ICU) perform in its most recent earnings report?
In the last report (June 30, 2026), LMF Acquisition Opportunities Inc posted an EPS surprise of 0% and a revenue surprise of 26.41%.
When is LMF Acquisition Opportunities Inc (ICU) next earnings report?
LMF Acquisition Opportunities Inc is expected to release its next earnings report on September 30, 2026.
What is LMF Acquisition Opportunities Inc (ICU) beta (volatility) score?
LMF Acquisition Opportunities Inc has a beta of -1.066, indicating lower volatility than the overall market.
